Status:
UNKNOWN
Immune Response of Haemodialysis Patients Post Covid-19 Vaccination
Lead Sponsor:
Penang Hospital, Malaysia
Conditions:
Immune Response Post Covid 19 Vaccination
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to assess immune response of end stage renal failure patients after Covid 19 vaccination
Eligibility Criteria
Inclusion
- ESRF patient on hemodialysis who are eligible for the goverment Covid 19 vaccination programme
- 18 years old and above
- consented to join the study
Exclusion
- patient who refused to be vaccinated
- patient who deemed unsuitable for Covid vaccination
Key Trial Info
Start Date :
April 27 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2022
Estimated Enrollment :
425 Patients enrolled
Trial Details
Trial ID
NCT04872751
Start Date
April 27 2021
End Date
April 1 2022
Last Update
May 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penang Hospital
George Town, Pulau Pinang, Malaysia, 10990